Decentralized Trial Operations Orchestrator
Coordinates telehealth home visits and local labs under a GCP-consistent operating model Evidence basis: FDA finalized decentralized trial guidance in 2024 and clarified oversight responsibilities for remote activities; European regulatory literature reports access gains with clear governance constraints
The Problem
“Fragmented decentralized trial operations create delays, compliance risk, and inconsistent participant experience”
Organizations face these key challenges:
Telehealth, home visit, and local lab scheduling are managed in disconnected systems
Remote activity oversight is hard to document consistently under GCP responsibilities
Operational issues are detected late because teams rely on static reports and manual follow-up
Participant logistics failures lead to missed visit windows and protocol deviations
Vendor integrations are brittle and create reconciliation work across CTMS, EDC, ePRO, and lab systems
Quality teams lack a reliable way to prioritize critical data and process signals
Non-interventional and decentralized studies often use fragmented tooling with inconsistent data quality
Study teams spend excessive time on status chasing instead of intervention and participant support
Impact When Solved
The Shift
Human Does
- •Review site, telehealth, and local lab activities manually
- •Coordinate participant visits and sample collection through spreadsheets and email
- •Check protocol and GCP compliance retrospectively
- •Escalate missed visits, delays, and documentation gaps after review
Automation
- •No AI-driven prioritization or orchestration
- •No continuous monitoring of remote activity status
- •No automated triage of operational risks or delays
Human Does
- •Approve oversight actions for telehealth and local lab exceptions
- •Review prioritized risks and decide intervention steps
- •Confirm protocol, GCP, and governance decisions for remote activities
AI Handles
- •Monitor decentralized trial activities across telehealth home visits and local labs
- •Prioritize operational risks, delays, and missing follow-ups for review
- •Generate coordinated task queues and reminders for time-sensitive actions
- •Flag compliance, documentation, and scheduling exceptions for human review
Operating Intelligence
How Decentralized Trial Operations Orchestrator runs once it is live
AI runs the first three steps autonomously.
Humans own every decision.
The system gets smarter each cycle.
Who is in control at each step
Each column marks the operating owner for that step. AI-led actions sit above the divider, human decisions and feedback loops sit below it.
Step 1
Assemble Context
Step 2
Analyze
Step 3
Recommend
Step 4
Human Decision
Step 5
Execute
Step 6
Feedback
AI lead
Autonomous execution
Human lead
Approval, override, feedback
AI handles assembly, analysis, and execution. The human gate sits at the decision point. Every cycle refines future recommendations.
The Loop
6 steps
Assemble Context
Combine the relevant records, signals, and constraints.
Analyze
Evaluate options, risk, and likely outcomes.
Recommend
Present a ranked recommendation with supporting rationale.
Human Decision
A human accepts, edits, or rejects the recommendation.
Authority gates · 1
The system must not make participant safety, quality, or compliance escalation decisions without review by the designated study oversight role. [S2][S4]
Why this step is human
The decision carries real-world consequences that require professional judgment and accountability.
Execute
Carry out the approved action in the operating workflow.
Feedback
Outcome data improves future recommendations.
1 operating angles mapped
Operational Depth
Technologies
Technologies commonly used in Decentralized Trial Operations Orchestrator implementations:
Key Players
Companies actively working on Decentralized Trial Operations Orchestrator solutions:
Real-World Use Cases
Tech-enabled decentralized clinical trial optimization
Use digital tools to run parts of a clinical trial remotely so patients participate more easily and sponsors finish studies faster and cheaper.
Unified AI platform for end-to-end non-interventional study management
Instead of stitching together many research tools, one platform handles consent, enrollment, records, and outcomes in a single system.
Critical data and process prioritization in clinical trial quality management
Before monitoring starts, the trial team decides which data and trial steps matter most for patient safety and trustworthy results, then watches those most closely.